{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:04:37Z","timestamp":1754111077006,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41429-018-0068-5","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T12:24:37Z","timestamp":1527164677000},"page":"831-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Activity of DNA-targeted C8-linked pyrrolobenzodiazepine\u2013heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions"],"prefix":"10.1038","volume":"71","author":[{"given":"Angelo","family":"Iacobino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Giannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanfranco","family":"Fattorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-2910","authenticated-orcid":false,"given":"Federico","family":"Brucoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"68_CR1","volume-title":"Global Tuberculosis Report 2017","author":"World Health Organization.","year":"2017","unstructured":"World Health Organization. Global Tuberculosis Report 2017. Geneva: WHO; 2017. WHO\/HTM\/TB\/2017.23."},{"key":"68_CR2","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun.","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127\u201335.","journal-title":"N Engl J Med"},{"key":"68_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.micinf.2016.10.001","volume":"19","author":"G Prosser","year":"2017","unstructured":"Prosser G, Brandenburg J, Reiling N, Barry CE 3rd, Wilkinson RJ, et al. The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. Microbes Infect. 2017;19:177\u201392.","journal-title":"Microbes Infect"},{"key":"68_CR4","doi-asserted-by":"publisher","unstructured":"Ca\u00f1o-Mu\u00f1iz S, Anthony R, Niemann S, Alffenaar JC. New approaches and therapeutic options for Mycobacterium tuberculosis in a dormant state. Clin Microbiol Rev. 2017;31 https:\/\/doi.org\/10.1128\/CMR.00060-17 .","DOI":"10.1128\/CMR.00060-17"},{"key":"68_CR5","doi-asserted-by":"publisher","unstructured":"Gold B, Nathan C. Targeting phenotypically tolerant Mycobacterium tuberculosis. Microbiol Spectr. 2017;5 https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0031-2016 .","DOI":"10.1128\/microbiolspec.TBTB2-0031-2016"},{"key":"68_CR6","doi-asserted-by":"crossref","unstructured":"Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5:291\u2013360.","DOI":"10.1016\/S2213-2600(17)30079-6"},{"key":"68_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol. 2014;12:159\u201367.","journal-title":"Nat Rev Microbiol"},{"key":"68_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1242\/dmm.019513","volume":"8","author":"JP Lanoix","year":"2015","unstructured":"Lanoix JP, Lenaerts AJ, Nuermberger EL. Heterogeneous disease progression and treatment response in a C3HeB\/FeJ mouse model of tuberculosis. Dis Model Mech. 2015;8:603\u201310.","journal-title":"Dis Model Mech"},{"key":"68_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/ijmy.ijmy_85_17","volume":"6","author":"A Iacobino","year":"2017","unstructured":"Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L. Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli. Int J Mycobacteriol. 2017;6:213\u201321.","journal-title":"Int J Mycobacteriol"},{"key":"68_CR10","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 1996;64:2062\u20139.","journal-title":"Infect Immun"},{"key":"68_CR11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1128\/AAC.02154-12","volume":"57","author":"G Piccaro","year":"2013","unstructured":"Piccaro G, Giannoni F, Filippini P, Mustazzolu A, Fattorini L. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions. Antimicrob Agents Chemother. 2013;57:1428\u201333.","journal-title":"Antimicrob Agents Chemother"},{"key":"68_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ja.2015.52","volume":"68","author":"G Piccaro","year":"2015","unstructured":"Piccaro G, Poce G, Biava M, Giannoni F, Fattorini L. Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis. J Antibiot. 2015;68:711\u20134.","journal-title":"J Antibiot"},{"issue":"3","key":"68_CR13","doi-asserted-by":"publisher","first-page":"pii: e02296","DOI":"10.1128\/AAC.02296-16","volume":"61","author":"A Iacobino","year":"2017","unstructured":"Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L. Mycobacterium tuberculosis is selectively killed by rifampin and rifapentine in hypoxia at neutral pH. Antimicrob Agents Chemother. 2017;61:pii: e02296\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"68_CR14","doi-asserted-by":"crossref","unstructured":"Sarathy JP, Via LE, Weiner D, Blanc L, Boshoff H, et al. Extreme drug tolerance of Mycobacterium tuberculosis in caseum. Antimicrob Agents Chemother. 2018;62:e02266\u201317.","DOI":"10.1128\/AAC.02266-17"},{"key":"68_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ja.2016.43","volume":"69","author":"F Brucoli","year":"2016","unstructured":"Brucoli F, Guzman JD, Basher MA, Evangelopoulos D, McMahon E, et al. DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities. J Antibiot. 2016;69:843\u20139.","journal-title":"J Antibiot"},{"key":"68_CR16","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1021\/ja00952a050","volume":"187","author":"W Leimgruber","year":"1965","unstructured":"Leimgruber W, Stefanovi\u0107 V, Schenker F, Karr A, Berger J. Isolation and characterization of anthramycin, a new antitumor antibiotic. J Am Chem Soc. 1965;187:5791\u20133.","journal-title":"J Am Chem Soc"},{"key":"68_CR17","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/jac\/dks127","volume":"67","author":"KM Rahman","year":"2012","unstructured":"Rahman KM, Rosado H, Moreira JB, Feuerbaum EA, Fox KR, et al. Antistaphylococcal activity of DNA-interactive pyrrolobenzodiazepine (PBD) dimers and PBD-biaryl conjugates. J Antimicrob Chemother. 2012;67:1683\u201396.","journal-title":"J Antimicrob Chemother"},{"key":"68_CR18","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1093\/jac\/dkx326","volume":"72","author":"L Hlaka","year":"2017","unstructured":"Hlaka L, Rosslee M, Ozturk M, Kumar S, Parihar SP, et al. Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy. J Antimicrob Chemother. 2017;72:3334\u201341.","journal-title":"J Antimicrob Chemother"},{"key":"68_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acsinfecdis.6b00051","volume":"2","author":"JP Sarathy","year":"2016","unstructured":"Sarathy JP, Zuccotto F, Hsinpin H, Sandberg L, Via LE, et al. Prediction of drug penetration in tuberculosis lesions. ACS Infect Dis. 2016;2:552\u201363.","journal-title":"ACS Infect Dis"},{"key":"68_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/nm.3937","volume":"21","author":"B Prideaux","year":"2015","unstructured":"Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, et al. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med. 2015;21:1223\u20137.","journal-title":"Nat Med"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0068-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-018-0068-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:10Z","timestamp":1684618270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-018-0068-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1038\/s41429-018-0068-5","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"type":"print","value":"0021-8820"},{"type":"electronic","value":"1881-1469"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}